Recent studies have shown that cisplatin exerts its anti-HCC effects by upregulating GADD45A expression, contributing to enhanced chemotherapeutic efficacy 26, but the precise molecular mechanisms by which GADD45A enhances chemosensitivity in hepatocellular carcinoma (HCC) remain incompletely understood. The gene discussed is GADD45A; the disease is hepatocellular carcinoma.